We hypothesized that AR-binding sites, hormone response elements for AR, are important to the susceptibility for PrCa incidence and progression considering the critical roles of AR on PrCa development and AR as a therapeutic target in PrCa in clinical settings39. The gene discussed is AR; the disease is pure red-cell aplasia.